BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3024491)

  • 1. Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment.
    Estrin M; Smith C; Huber S
    Am J Pathol; 1986 Nov; 125(2):244-51. PubMed ID: 3024491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
    Huber SA; Lyden DC; Lodge PA
    Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes.
    Guthrie M; Lodge PA; Huber SA
    Cell Immunol; 1984 Oct; 88(2):558-67. PubMed ID: 6091924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.
    Estrin M; Huber SA
    Am J Pathol; 1987 May; 127(2):335-41. PubMed ID: 3034068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.
    Huber SA; Lodge PA
    Am J Pathol; 1984 Jul; 116(1):21-9. PubMed ID: 6331168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
    Chang H; Han B; Han XZ
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice.
    Huber SA; Job LP
    Adv Exp Med Biol; 1983; 161():491-508. PubMed ID: 6307010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggravation of coxsackievirus, group B, type 3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone.
    Lyden DC; Huber SA
    Cell Immunol; 1984 Sep; 87(2):462-72. PubMed ID: 6088088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.
    Huber SA; Lodge PA
    Am J Pathol; 1986 Feb; 122(2):284-91. PubMed ID: 3004227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis.
    Neumann DA; Rose NR; Ansari AA; Herskowitz A
    J Immunol; 1994 Jan; 152(1):343-50. PubMed ID: 8254202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis.
    Job LP; Lyden DC; Huber SA
    Cell Immunol; 1986 Mar; 98(1):104-13. PubMed ID: 3017580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elution of autoantibodies from the hearts of coxsackievirus-infected mice.
    Neumann DA; Lane JR; LaFond-Walker A; Allen GS; Frondoza C; Herskowitz A; Rose NR
    Eur Heart J; 1991 Aug; 12 Suppl D():113-6. PubMed ID: 1655441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA4-Ig relieves inflammation in murine models of coxsackievirus B3-induced myocarditis.
    Han B; Jiang H; Liu Z; Zhang Y; Zhao L; Lu K; Xi J
    Can J Cardiol; 2012; 28(2):239-44. PubMed ID: 22336520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice.
    Kishimoto C; Hiraoka Y; Takada H
    Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.
    Loudon RP; Moraska AF; Huber SA; Schwimmbeck P; Schultheiss P
    J Virol; 1991 Nov; 65(11):5813-9. PubMed ID: 1656071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis.
    Huber SA; Stone JE; Wagner DH; Kupperman J; Pfeiffer L; David C; O'Brien RL; Davis GS; Newell MK
    J Virol; 1999 Jul; 73(7):5630-6. PubMed ID: 10364312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice.
    Kishimoto C; Ochiai H; Sasayama S
    Jpn Circ J; 1991 Nov; 55(11):1144-8. PubMed ID: 1721094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.